Navigation Links
Bonn researchers use light to make the heart stumble
Date:10/4/2010

This release is available in German.

Tobias Brgmann and his colleagues from the University of Bonn's Institute of Physiology I used a so-called "channelrhodopsin" for their experiments, which is a type of light sensor. At the same time, it can act as an ion channel in the cell membrane. When stimulated with blue light, this channel opens, and positive ions flow into the cell. This causes a change in the cell membrane's pressure, which stimulates cardiac muscle cells to contract.

"We have genetically modified mice to make them express channelrhodopsin in the heart muscle," explains Professor Dr. Bernd Fleischmann of the Institute for Physiology I. "That allowed us to change the electric potential of the mouse heart at will, enabling us to selectively produce conditions such as arrhythmia of the atrium or the ventricle."

These types of arrhythmia - physicians also call them ventricular fibrillation - are among the most common causes of death after a heart attack. They develop when large quantities of cardiac cells die and are replaced with connective tissue. "This scar tissue has a different electrical activity than the healthy heart muscle," says the leader of the study, Professor Dr. Philipp Sasse. "And that makes the heart stumble."

But why is that so? Normally, electric impulses spread across the heart from a natural pacemaker. This happens in a temporally and spatially tightly controlled manner, creating a closely coordinated contraction. However, if entire muscle areas decouple electrically, this mechanism no longer works: all of a sudden, certain parts of the heart pulse at their own rhythm. This causes the blood flow to come to a near-standstill.

The scientists from Bonn can now trigger this decoupling through photostimulation. They can target just a few cells at a time or direct larger areas of the heart, allowing them to find out, for instance, which areas of the hollow muscle are especially sensitive to electric disruptions.

But why not simply stimulate the heart muscle with electrodes in order to make the heart lose its rhythm? "That can be done as well," says Professor Sasse. " But this method has unwanted side effects: if the electric stimulation lasts longer than a few milliseconds, toxic gases are produced, and the pH value changes."

The consequences of a heart attack, which leads to permanent tissue damage, can of course only be studied in a very limited form when using short-term electric stimulation. Photostimulation is much more suitable: the cells will even withstand stimulations of several minutes at a time without problems.

Using channelrhodopsin in medical research is not fundamentally new, although so far it has mainly been used in neuroscience. For instance, scientists can use these light channels to direct the behavior of flies and mice - with nothing but blue light.


'/>"/>

Contact: Professor Dr. Philipp Sasse
philipp.sasse@uni-bonn.de
49-228-688-5212
University of Bonn
Source:Eurekalert

Related biology news :

1. Researchers engineer adult stem cells that do not age
2. OU researchers selected by Navy
3. Researchers find first genetic evidence for loss of teeth in the common ancestor of baleen whales
4. McLean Hospital researchers awarded $1.9 9 million grant for stem cell, blood research
5. WSU researchers taking sustainability of organic farming to new level
6. Purifying proteins: Rensselaer researchers use NMR to improve drug development
7. Smithsonian researchers find differences between Galapagos and mainland frigatebirds
8. Iowa State, Ames Lab researchers identify structure that allows bacteria to resist drugs
9. Vitamin C rapidly improves emotional state of acutely hospitalized patients, say LDI researchers
10. BUSM researchers to study vitamin D production in fat malabsorption patients
11. Cardiovascular Innovation Institute researchers receive over $2 million grant from NIH
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2017)... 6, 2017 Mintigo , the ... announced Predictive Sales Coach TM , its new ... intelligence into Salesforce. This unique AI application will ... organizations with deep knowledge of their customers and ... engagement. Predictive Sales Coach extends Mintigo,s existing customer ...
(Date:3/2/2017)... -- Australian stem cell and regenerative medicine company, ... agreement with the Monash Lung Biology Network, a consortia ... Department of Pharmacology at Monash University, Melbourne ... support the use of Cymerus™ mesenchymal stem cells (MSCs) ... is a chronic, long term lung condition recognised by ...
(Date:2/28/2017)...  EyeLock LLC, ein marktführendes Unternehmen im Bereich ... Lösung zur Iris-Erkennung auf der neuesten Mobilplattform ... dem Mobile World Congress 2017 (27. Februar ... 3, Stand 3E10, vorstellen. Der ... – eine Kombination aus Hardware, Software und ...
Breaking Biology News(10 mins):
(Date:3/24/2017)...   Sienna Biopharmaceuticals, Inc. , a privately held, ... Richard Peterson will join the company as ... who brings more than two decades of global financial ... retiring at the end of April but will continue ... Sienna from Novan, Inc., where he served as Chief ...
(Date:3/23/2017)... ... 2017 , ... AxioMed president, Jake Lubinski, describes the AxioMed ... deformed, which is identical to how the human discs work to distribute force. ... to its natural state along a hysteresis curve, exactly like a healthy human ...
(Date:3/23/2017)... DUBLIN , Mar 23, 2017 ... "Biorefinery Products: Global Markets" report to their offering. ... The ... from $466.6 Billion in 2016 at a CAGR of 8.9%, ... of energetic and non-energetic bioproducts into seven major product segments: ...
(Date:3/23/2017)... March 23, 2017  SeraCare Life Sciences, ... in vitro diagnostics manufacturers and clinical laboratories, ... first multiplexed Inherited Cancer reference material ... by next-generation sequencing (NGS). The Seraseq™ Inherited Cancer ... input from industry experts to validate the ...
Breaking Biology Technology: